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Abstract
The MLK family of mitogen activated protein kinase kinase kinases (MAPKKK) has been shown to activate Jun N-terminal
kinase/stress-activated protein kinase 1 (JNK/SAPK1). However, little is known of the in vivo functions of the MLKs. We have identified
a Xenopus laevis MLK that shows highest homology with mammalian MLK2 (62%) and, like MLK2, interacts preferentially with the
Rho-family GTPase Rac. xMLK2 was expressed zygotically from late gastrula/early neurula. Surprisingly, this expression was restricted to
the cement gland, the brain, and the pronephros. In the differentiating cement gland, xMLK2 expression correlated with cell elongation and
the onset of a previously unobserved apoptotic phase, while in the pronephros, expression corresponded with the differentiation and opening
of the nephric tubules. Overexpression of xMLK2 in COS7 cells led to a SEK1/MKK4 (MAPKK)-dependent hyperactivation of JNK in
response to UV irradiation. xMLK2 was shown to be required for normal cement gland development and pronephric tubule formation using
antisense inactivation and a dominant negative xMLK2. The data suggest a novel role for the MLKs as tissue-restricted mediators of signal
transduction. They also suggest that tissue-specific responses to common extracellular signals may in part result from the programmed
expression of MAPKKKs with differing specificities.
© 2003 Elsevier Science (USA). All rights reserved.
Keywords: Xenopus; Signal transduction; Cement gland; Pronephros; Programmed cell death; Mixed lineage kinase 2; (MLK2, MST, MAP3K10);
JNK/SAPK1
Introduction
Extracellular signalling plays a key role during the de-
velopment and organogenesis of multicellular organisms.
However, a relatively limited number of signalling path-
ways appear to exist, suggesting that any given signal may
lead to multiple outcomes dependent on developmental
stage and cell type. In part, this specificity of signal trans-
duction is achieved by the expression of varying combina-
tions of cell surface receptors and ligands. However, the
wealth of responses displayed by the different tissue and
cell types of higher organisms may also depend on varia-
tions in the intracellular circuits used to transduce given
signals. The mitogen-activated protein kinase (MAPK) cas-
cades are responsible for transducing many of the extracel-
lular signals into an appropriate genetic response (Hazzalin
and Mahadevan, 2002, and references therein). These cas-
cades consist of three or four protein kinases, often present
as a multimolecular complex. In the simplest case, these
kinases transmit a unidirectional phosphorylation signal,
leading to the activation of a MAPK that is responsible for
reprogramming nuclear gene expression. The cascade ter-
minating in the activation of Jun N-terminal kinase/stress-
activated protein kinase 1 (JNK/SAPK1) has been impli-
cated in many key developmental functions, including
migration, differentiation, and programmed cell death
(Kyriakis and Avruch, 2001, and references therein). This
cascade transduces signals from a broad range of cell sur-
face receptors, including G-protein-coupled and tyrosine
kinase receptors. Particularly interesting in the context of
both development and cancer are the frizzled family of Wnt
receptors and the Eph family of ephrin receptors that control
cell migration and mesenchyme–epithelial transitions. Un-
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derstanding how and why JNK is activated in response to
signalling through these receptors is of key importance to
understanding the role of these pathways in development
and cancer. A large number of apparently redundant protein
kinases has been identified for each level of the JNK sig-
nalling cascade. For example, six or more potential JNK
kinase kinases (JNKKK) have been identified (e.g.,
Stronach and Perrimon, 2002). It is possible that these
JNKKKs play a role in determining the appropriate re-
sponses of JNK to extracellular signals. However, little is
presently known of the spatial and temporal expression of
the JNKKKs during vertebrate development or of their in
vivo functions. Here, we show that at least one JNKKK, a
member of the mixed lineage kinase (MLK) family, is
specifically expressed in the cement gland and primitive
kidney during organogenesis in Xenopus and is required for
the differentiation of these tissues.
The early stages of Xenopus development provide an
ideal model system in which to study vertebrate organogen-
esis. Both the cement gland and the embryonic kidney form
rapidly from tissues determined just before or immediately
after neural tube closure. The cement gland (CG) presents
the simplest type of organ. A predetermined group of ecto-
dermal cells first elongates then begins to secrete mucus that
allows the hatched larvae to attach to solid objects in the
water. The embryonic kidney, on the other hand, is probably
one of the most complex of organs, requiring a precise
juxtaposition of several different tissue types and the for-
mation of connecting tubules and ducts (Bra¨ndli, 1999; Vize
et al., 1997). Lower vertebrates form three independent
kidneys during their development: the pronephros, the me-
sonephros, and the metanephros, most probably to cope
with the changing conditions to which the organism is
exposed. All three forms of kidney, however, play the same
role, i.e., blood filtration, and differ structurally from each
other predominantly in the number of filtration units or
nephrons. In Xenopus, the pronephros becomes a functional
kidney composed of only three nonintegrated nephrons.
This is in contrast to the meso- and metanephros, where the
glomerulus becomes integrated into the tip of a kidney
tubule forming the Bowman’s capsule. The nonintegrated
nephrons of the pronephros are characterized by filtration
units or glomeruli located near a body cavity called the
nephrocoelom or coelom. Blood is filtered and waste is
stored in the coelom and is sent to the pronephric tubules by
the movement of ciliated funnels called nephrostomes
(Nieuwkoop and Faber, 1967; Vize et al., 1997). Hence, the
structure of the pronephros is very much simpler than that of
the mesonephros or the metanephros.
Differentiation of both the CG and the pronephros involves
the formation of epithelia, but these epithelia are derived from
different embryonic cell layers. In the case of the CG, primor-
dial epidermal cells align and elongate to form a thick epithelia
sheet corresponding to the functional organ (Nieuwkoop and
Faber, 1967). The pronephros, on the other hand, develops
from an anlage formed by the condensation of somatic and
inner intermediate mesoderm, giving rise, respectively, to the
lateral pronephric tubules and the more medial pronephric
capsule or glomus (Bra¨ndli, 1999; Vize et al., 1995). Proneph-
ric tubule development presents a relatively simple in vivo
model for the formation of a luminated epithelium. In several
model systems, the formation and migration of epithelia have
been shown to involve small GTPases of the Rho family and
to be under control of the JNK MAP kinase (MAPK) pathway
(see Noselli and Agne`s, 1999; Tickle and Altabef, 1999). In
Drosophila, polarity of epithelial sheets has been shown to
involve signalling through the Wnt/Frizzled pathway via Dsh
and the MSN kinase to JNK and to the cytoskeleton (Boutros
and Mlodzik, 1999; Noselli and Agne`s, 1999). The phenome-
non of dorsal closure, an epithelial sheet extension, depends on
JNK activation via a similar pathway (Noselli and Agne`s,
1999). The MAPKKKK, DPAK, has been implicated in dorsal
closure (Harden et al., 1996), and more recently, the MAP-
KKK gene slipper, which codes a homologue of the mamma-
lian MLK kinases, has been shown to be essential for dorsal
closure and to mediate Wnt activation of JNK.
The mammalian MLKs have been shown to be important
mediators of JNK activation, hMLK2 and hMLK3 constitu-
tively activating this pathway when overexpressed in mamma-
lian cells (Hirai et al., 1996, 1997; Tibbles et al., 1996). Fur-
thermore, MLK3, MKK4, and JNK were all found to bind to
the same “scaffold” protein JIP, forming a signalling module
(Whitmarsh and Davis, 1998) that is responsive to members of
the GC kinase family to which Drosophila MSN belongs
(Whitmarsh and Davis, 1998). When Swiss 3T3 cells were
injected with an hMLK2 expression vector, JNK and hMLK2
were found to colocalise (Nagata et al., 1998). hMLK2-ex-
pressing cells underwent apoptosis, an observation consistent
with many reports that JNK activation predisposes to or is a
component in apoptosis or programmed cell death (PCD)
(Basu and Kolesnick, 1998; Dhanasekaran and Reddy, 1998;
Kuan et al., 1999; Low et al., 1999).
Here, we report the cloning of the X. laevis MLK2
(xMLK2), its spatial and temporal expression during devel-
opment, its biochemical activities, and the requirement for
this kinase during organogenesis. The data show that
xMLK2 is a tissue-restricted MAPKKK for the JNK path-
way required for the differentiation of both the CG and the
pronephric tubules. The data suggest that tissue-restricted
expression of specialised MAPKKKs could play an impor-
tant role in the genetic programming of differentiation by
mediating cell-specific transduction and hence cell-specific
responses to common extracellular signals.
Materials and methods
Cloning and sequencing
A first clone of xMLK2 was isolated by the use of
degenerate primers corresponding to kinase domains VIII
and IX in a PCR on stage 24 cDNA (Islam et al., 1994). This
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clone, xltk23, was then transcribed as a riboprobe and used
to screen a X. laevis brain-derived gt10 cDNA bank pre-
pared by K. Richter and provided by T. Sargent. Screening
of this bank was performed in 50% formamide, 5 SSC,
5 Denhardt’s, and 100 g/ml torula RNA (Sigma) at
42°C. After hybridization, washing consisted of two washes
in 6 SSC and two washes in 2 SSC at 42°C for 15 min
each. The filters were then treated with RNase A, 20 g/ml
and RNase T1, 10 units/ml in 2 SSC at 37°C for 30 min
before further washing in 0.5 SSC, 0.1% SDS at 55°C for
30 min. A partial cDNA was isolated, subcloned into
pUC19U, and sequenced by using Exo III deletion (Phar-
Fig. 1. Primary structure of xMLK2 and comparison with those of human MLK2 and MLK3. (A) Amino acid sequence of xMLK2 aligned with those of
human MLK2 (hMLK2) (GenBank Accession No. Z48615) and human MLK3 (hMLK3) (GenBank Accession No. L32976), identical sequences are marked
by gray boxes. The identity between xMLK2 and hMLK2 is 66.6% and that between xMLK2 and hMLK3 is 49.5%. The sequence named MLK is the
consensus sequence of this comparison. The GCG programs GAP and LINEUP were used to obtain this alignment (Devereux et al., 1984). (B) Schematic
representation of xMLK2 showing the Src-Homology-3 domain (SH3), serine/threonine kinase domain (Kinase), leucine zipper motifs (LZ), basic region,
p21 GTPase Binding Domain (GBD), and SH3 domain binding sites (SH3BD).
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macia). In order to obtain the 5 cDNA sequences, a 5
RACE-PCR was performed by using the Marathon cDNA
amplification kit (Clontech). A total of 2 g of stage 50
poly(A) mRNA was reverse-transcribed with random
primers. Marathon adapters were ligated to this cDNA be-
fore PCR with AP1 (Clontech) and 6tkc6.4.rev (5-CCG-
TACAAAAGGCTCAGGACAAGT) primers. After a sec-
ond PCR amplification using AP2 and 6tkc6.5.rev (5-
CAAGTCGATG GGATAGGTAAGGTA) primers, 1/10 of
the PCR was fractionated on 1% agarose gel, and the gel
was transferred to nitrocellulose membrane (Amersham)
and hybridized with [-32P] riboprobe covering bases 883-
1058 of the xMLK2 cDNA. Positives bands were subcloned
in pUC19U and sequenced again by using Exo III deletion.
Northern and RT-PCR
mRNA was isolated from staged embryos and adult
tissues by using guanidinium isothiocyanide and LiCl pre-
cipitation (Cathala et al., 1983). Northern blot was prepared
from formaldehyde gel separation (Brown, 1987). The blot
contained 20 g per lane of total RNA from each stage and
was probed with an [-32P]RNA antisense probe corre-
sponding to nucleotides 981–1540. Hybridization was per-
formed in 50% formamide, 6 SSC, 5 Denhardt’s, and
100 g/ml of torula RNA (Sigma) at 60°C. After hybrid-
ization, washing consisted of two washes in 6 SSC and
two washes in 2 SSC at 60°C for 15 min each. The blot
was washed in 0.5 SSC, 0.1% SDS, and 0.1 SSC, 0.1%
SDS at 65°C for 15 min each. Finally, the blot was washed
again in 0.1 SSC, 0.1% SDS at 68°C for 15 min. For
RT-PCR, 10 g of total RNA from tissues and 2 g of
poly(A) RNA from stage 42 embryos (CTRL  and )
were used in a reverse transcription reaction with a specific
reverse primer, 6tkc6.rev3 (5-ATGGCTGACTGTTC-
TAT). Reverse transcription reaction of CTRL was made
without reverse transcriptase. PCR was performed on
1/40, 1/20, and 1/10 of each RT reaction with oligonu-
cleotides 6tkc6.for2 (5-GAGCAGTGATGTGTGGA) and
6tkc6.rev4 (5-CCGTACAAAAGGCTCAGGACAAGT).
One-tenth of each PCR was put on gel, transferred, and
hybridized with [-32P]RNA probe covering nucleotides
981–1140. Hybridization was performed in 50% form-
amide, 6 SSC, 5 Denhardt’s, and 100 g/ml of torula
RNA (Sigma) at 42°C. After hybridization, washing con-
sisted of two washes in 6 SSC and two washes in 2 SSC
at 60°C for 15 min each. The membrane was then treated
with RNase A, 20 g/ml, and RNase T1, 10 units/ml, in 2
SSC at 37°C for 30 min before further washing in 0.5
SSC, 0.1% SDS at 55°C for 30 min.
Plasmids and constructs
xMLK2 cDNA was amplified by using oligonucleotides
6tkc6.tag (5-GGAATTCCGATGGACTTCCGAAAGA)
and 3 6tkc6.rev (5-GGAATTCCCACAAAACACAT-
TCAT). After digestion with EcoRI, this fragment was
subcloned into pT7TS (P. Krieg) modified by the insertion
of an HA1 epitope sequence. The unique EcoRI site of
pT7TS was first eliminated by digestion with EcoRI, fill-out
with Klenow polymerase, and religation. An EcoRI linker
was then inserted at the unique EcoRV site. Hemagglutinin
epitope (HA1) was PCR amplified from a p44-tagged MAP-
kinase construct (Wilson et al., 1984) by using primers
HA1tag1.gen (5-AGATCTAAGCTTGCCGCCACCATG)
and HA1tag2.rev (5-GAATTCCCCGGGAGGCT) and in-
serted (Bg1II/EcoRI) into the modified pT7TS. In vitro-
coupled transcription–translation (Promega) was performed
on this construct as recommended by manufacturer. The
kinase dead form of xMLK2 (K146R) was created by PCR
Fig. 2. xMLK2 is expressed as a zygotic message during early development
as well as in adult tissues. (A) Northern analysis of xMLK2 mRNA
expression during X. laevis development from stage 0 (Oocytes) to stage
45. Blot contained 20 g per lane of total RNA from each stage and was
probed with an [-32P]RNA antisense probe corresponding to nucleotides
981–1540 of the xMLK2 cDNA. (B) RT-PCR analysis of xMLK2 mRNA
expression in adult X. laevis tissues. A total of 10 g of total RNA from
tissues and 2 g of poly(A) RNA from stage 42 (St. 42  and ) were
used in a reverse transcription (RT) reaction with the specific reverse
primer 6tkc6.rev3, starting at nucleotide 1250 (See Materials and methods).
Reverse transcriptase was omitted from the “St 42” reaction. Fifteen
cycles of PCR were then performed on 1/40, 1/20, and 1/10 of each RT
reaction with oligonucleotides 6tkc6.for 2 and 6tkc6.rev4, nucleotides
1002–1147. One 10th of each PCR was agarose gel fractionated, trans-
ferred to Hybond-N (Amersham; old version), and hybridized with an
xMLK2 [-32P]RNA probe containing nucleotides 981–1140. (C) Western
analysis of xMLK2 protein expression in various tissues. The Western blot
contained 20 g per track of total protein isolated from the various tissues
and was probed with a polyclonal antibody raised against amino acids
1–154 of xMLK2. Coupled in vitro transcription–translation (Promega)
was performed on the full-length xMLK2 cDNA as control.
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using a mismatch primer and verified by sequencing. The
dominant negative xMLK2 construction was obtained by
cloning the coding region for aa 384–503 of xMLK2 down-
stream of the HA epitope in the modified T7TS vector (see
above) and upstream of aa 5–236 of EGFP-Cl (Clontech).
After cleaving vectors with XbaI, mRNAs for embryo in-
jection were synthesised by using the T7 mMessage mMa-
chine (Ambion) as recommended by the manufacturers.
Antibody production
Rabbit polyclonal antibody against xMLK2 was gener-
ated by injection of bacterial-expressed GST fusion protein
containing xMLK2 residues 1–154. Two rabbits were in-
jected with 750 g of GSTxMLK2 and boosted twice at an
interval of 18 days. Twenty days after the second boost,
rabbits were sacrificed and blood was recovered. Blood was
kept overnight at 4°C to allow coagulation. It was then
centrifuged, and the serum was recovered and stored at
80°C.
Western analysis
Tissues from adult X. laevis frogs were homogenized in
extraction buffer (250 mM Sucrose, 10 mM Tris, pH 7.4, 1
mM EGTA, and 1 mM MgCl2) and centrifuged to removed
cellular debris. Proteins from tissue lysates were separated
on an 8% SDS acrylamide gel and electrophoretically trans-
ferred to Hybond-C membrane (Amersham) in 25 mM Tris,
192 mM glycine, and 20% methanol. Membranes were
blocked in PBS (145 mM NaCl, 10 mM Na-phosphate
buffer, pH 7.4) containing 2.5% dry milk. The membranes
were then incubated with xMLK2 1-154 polyclonal anti-
body (1/500) in PBS containing 1% dry milk for 2 h at room
temperature. After washing with PBS and 1% dry milk,
blots were incubated with horseradish peroxidase-conju-
gated donkey anti-rabbit IgG (1/5000) in PBS, 1% dry milk.
Fig. 3. Early zygotic expression of xMLK2 was detected by whole-mount in situ hybridization in the cement gland, pronephros, and brain. (A) xMLK2 mRNA
was first detected at stage 22 in the cement gland (CG). (B) By stage 24, xMLK2 was noted most strongly in the peripheral of the cement gland. (C) Stage
25 embryos showed two concentric rings of expression around the cement gland. The eye anlage is outlined in gray. (D) In situ hybridization with the early
cement gland marker, xCG (Sive et al., 1989), on stage 25 embryo showed staining around the cement gland. (E) Stage 30 embryo showing expression in
the cement gland and in the pronephric anlage (PA). (F and G) Stage 32 and 36 embryos showing xMLK2 expression in the developing pronephros (P) and
weakly in the pronephric duct (PD). (H) Stage 37, xMLK2 was expressed in the functional pronephros (P) and much more weakly in the pronephric duct.
Panels are lateral views with anterior to left.
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The blots were developed by using Renaissance (NEN-
Dupont) Western blot chemiluminescence reagents.
Whole-mount in situ hybridization
Whole-mount in situ hybridization was carried out on
albino X. laevis (Nasco) as described (Hemmati-Brivanlou
et al., 1990; Jowett and Lettice, 1994) with some modifica-
tions to avoid the need for manual removal of the vitelline
membrane from prehatching stage embryos (Islam and
Moss, 1996). Sectioning was carried out after whole-mount
hybridization by standard paraffin embedding.
Whole-mount immunohistocytochemistry
Whole-mount immunohistocytochemistry was carried
out on X. laevis embryos based on the whole-mount in situ
hybridization protocol with some modifications. Since the
second antibody was conjugated to a peroxidase enzyme,
intrinsic peroxidase was inactivated by incubation of the
fixed embryos with 10% H2O2 in methanol for 30 min at
room temperature (RT). After the refixation step, embryos
were incubated in the antibody blocking solution [5% goat
serum, 2 mg/ml BSA (Cohn frac. V, Sigma) and 1% DMSO
Fig. 4. The onset of xMLK2 expression corresponds with epithelialisation of the proximal pronephric tubules. (A) Whole-mount in situ views compared with
a schematic representation of the developing pronephros adapted from (Vize et al., 1995). All panels are lateral views with anterior to the left. Expression
closely followed the differentiation of each proximal tubule branch, starting with the most anterior one, see stage 28–29, and moving towards the most
posterior one by stage 35–36. At stages 36 and 37–38, expression was restricted to the proximal tubules and probably to the connecting common tubule. In
the schematic, dark shading represents the proximal and common tubule tissue, where xMLK2 is expressed, and light shading the pronephric duct. Dotted
line on stage 37–38 pronephros traces the weak xMLK2 staining in the pronephric duct. (B) Transverse section through the pronephros of a stage 37 X. laevis
embryo stained for xMLK2 by whole-mount in situ hybridization. (C) Schematic representation of a transverse embryo section at the level of the pronephros
at stage 36 showing the localisation of the pronephric tubules, duct, glomus and coelom, adapted from Vize et al., 1995. (D and E) xMLK2 was expressed
in pronephric tubule epithelium. In these sections, tubules were oriented in an anterioposterior (D) or dorsoventral (E) fashion. (F) enlargement of an
xMLK2-stained section showing both anterioposterior and dorsoventral oriented tubules. PT, pronephric tubules; E, epiderm.
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in PBST] for 1 h at RT and then incubated with the preab-
sorbed first antibody for 2 h at RT. Mouse monoclonal
antibody 3G8 was used in this first incubation (Vize et al.,
1995). The embryos were washed extensively in PBST (12
times for 15 min). This step was followed by second anti-
body incubation. Staining was performed by using DAB
substrate (500 g/ml in 0.05% Nickel chloride) as recom-
mended by manufacturer (BCL).
Microinjection of X. laevis embryos
Embryos were produced by in vitro fertilization (New-
port and Kirschner, 1982) and were staged according to
Nieuwkoop and Faber (1967). Two-cell embryos in 0.2
MMR (20 mM NaCl, 0.5 mM KCl, 0.2 mM MgSO4, 0.5
mM CaCl2, 1 mM HEPES, and 0.02 mM EDTA), 5% Ficoll
400 were injected with 2 ng of xMLK2 or mutant mRNAs
and allowed to develop for 18 h. Gastrula embryos were
lysed in MGE lysis buffer (20 mM MOPS, pH 7.0, 10%
glycerol, 0.5 mM EDTA, 5 mM EGTA, 1 mM NaVO4, 5
mM sodium pyrophosphate, 50 mM NaF, 80 mM -glyc-
erophosphate, 1% Triton X-100, 0.1 mM benzamidine, 0.1
mM DTT, and 0.1 mM PMSF) and were centrifuged at
30,000 rpm for 30 min. The clear protein phase was recov-
ered and analyzed for expression by Western blotting using
the monoclonal antibody 12CA5.
Morpholino experiments
The antisense (match) xMLK2 Morpholino (5-
ATCTTTCGGAAGTCCATCCATCCAT-3) and mismatch
Morpholino (5-ATgTTTgGGAAGTCCATgCATgCAT-
3) (Gene Tools) corresponded to nucleotides 4 to 21
(Gene Tools) of xMLK2 mRNA relative to the ATG. The
Morpholino was diluted at 0.2 mM, and 1–10 nl was in-
jected into one-blastomere of two-cell-stage embryos. Em-
bryos were allowed to develop to the appropriate stage
before analysis, protein extraction (as described above), or
fixation in formaldehyde. To determine the effects on trans-
lation, mRNA corresponding to the complete xMLK2
cDNA or a truncated HA-tagged xMLK2 (HA-xMLK2 aa
1–659) were injected in X. laevis embryos in the presence
or absence of xMLK2 Morpholino. Phenotypic analyses
were made by measuring the diameter of eye and prone-
phros as viewed from the dorsolateral direction by using a
graticule on a binocular microscope. Rescue of the Mor-
pholino effects were achieved by coinjecting mRNA encod-
ing the full-length HA-tagged xMLK2. Sectioning was car-
ried out by standard paraffin embedding.
Cells culture, transfection, immunoprecipitation, and
kinase assay
COS7 cells were cultured in Dulbecco’s modified eagle
medium (DMEM) supplemented with 10% fetal calf serum.
The day before transfection, 3  105 cells were plated on
100-mm tissue culture dishes. Two hours before the trans-
fection, medium was changed for fresh medium. Standard
calcium chloride precipitation procedure was used for trans-
fection. Twenty-four hours later, cells were lysed in MGE
lysis buffer and centrifuged at 17,000 rpm for 10 min.
Cleared lysates were normalized for equal protein concen-
tration of HA-JNK and were immunoprecipitated by using
12CA5 (HA) monoclonal antibody. Immunoprecipitated
complexes were harvested on protein-A Sepharose beads
(Pharmacia). For JNK kinase assay, immunoprecipitates
were washed five times with MIKI (20 mM Tris–HCl, pH
7.5, 150 mM NaCl, 0.1 mM EDTA, 1 mM EGTA, 1 mM
MgCl2, 1 mM NaVO4, 1% Triton X-100, and 1 mM PMSF),
and kinase assays were performed in MPM buffer (150 M
ATP, 15 mM MOPS, pH 7, 5% glycerol, 60 mM p-nitro-
phenylphosphate, 15 mM MgCl2, 1 mM DTT, and 0.1 mM
PMSF) in the presence of 3 Ci of [-32P]ATP and 2 g of
GST-c-Jun. The reaction was stopped by adding 6 SDS
gel sample buffer. Phosphoproteins were separated on SDS-
PAGE and transferred to nitrocellulose membranes. Radio-
active bands were visualized by phosphorimaging (Molec-
ular Dynamics). For UV treatment, 1 h before harvesting,
cells were treated with 100 J/m2 of UV irradiation by using
a UVP UVGL-25 (Ultra-Violet Products).
GTPases binding assay
GTPase binding assay for xMLK2 and 2 g of immobi-
lized GST-Cdc42, Racl, or RhoA (vectors supplied by A.
Hall) were incubated with GTP or GDP in Exchange Buffer
(50 mM Tris, pH 7.5, 5 mM EDTA, and 0.5 mg/ml bovine
serum albumin) for 10 min at 30°C. MgCl2 was then added
to 10 mM on ice. GTPases loaded with GTP or GDP were
incubated with a total extract from X. laevis embryos ex-
pressing full-length xMLK2 for 1 h at 4°C. The immobi-
lized protein complexes were washed three times with 500
L of PBS (145 mM NaCl, 10 mM Na-phosphate buffer,
pH 7.4) and three times with TBS. Bound xMLK2 was
visualized by immunoblotting with 12CA5 antibody.
TUNEL assay
Whole-mount TUNEL assay was carried out on albino X.
laevis (Nasco) as follows. Embryos were fixed in MEMFA
(0.1 M MOPS, pH 7.4, 2 mM EGTA, 1 mM MgSO4, and
3.7% formaldehyde) and stored in methanol (MeOH) at
20°C. They were rehydrated by sequential washings in
75% MeOH–25% PBST (PBS with 0.1% Tween 20), 50%
MeOH–50% PBST, 25% MeOH–75% PBST, and finally in
PBST. Embryos were then equilibrated in terminal deoxy-
nucleotidyl transferase (TdT) buffer (200 mM potassium
cacodylate, 25 mM Tris–HCl, pH 6.6, 5 mM CoCl2, 0.25
mg/ml BSA) and incubated with 150 units/ml of TdT
(Boehringer Mannheim) and 0.5 M digoxigenin–dUTP
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(Boehringer Mannheim) for 1 h at 37°C. TdT reaction was
stopped and endogenous alkaline phosphatase inactivated
by incubation in 0.1 M Glycine, 0.1% Tween 20, pH 2.5, for
40 min. Embryos were blocked with blocking solution [5%
sheep serum, 2 mg/ml BSA (Cohn frac. V), 1% DMSO in
PBST] for 1 h. Then, embryos were incubated with anti-
digoxygenin antibody conjugated with alkaline phosphatase
(Boehringer Mannheim) in blocking solution for 15–18 h at
4°C. Anti-digoxygenin antibody was preabsorbed with heat-
inactivated X. laevis embryo powder for 1 h at room tem-
perature before incubation with the labelled embryos. Em-
bryos were washed 10 times (15 min) with PBST and
equilibrated in NTMT (100 mM Tris–HCl, pH 9.0, 100 mM
NaCl, 5 mM MgCl2, and 0.1% Tween 20). Staining was
performed by using 4-nitro blue tetrazolium chloride (NBT)
(Boehringer Mannheim) and 5-bromo-4-chloro-3-indolyl-
phosphate, 4-toluidine salt (BCIP) (Boehringer Mannheim)
in NTMT as recommended by manufacturer. Sectioning
was carried out after whole-mount TUNEL assay by stan-
dard paraffin embedding. This TUNEL protocol was estab-
lished independently and prior to the published protocol
(Hensey and Gautier, 1998), which it closely resembles.
Results
In order to identify protein kinases implicated in the
development of X. laevis, we used degenerate primers to
kinase domains VIII and IX to perform RT-PCR on stage 24
embryo mRNA (Islam et al., 1994). Though many of the
gene fragments we isolated encoded Xenopus potential or-
thologues of previously identified receptor and intracellular
signalling kinases, 11 carried novel open reading frames.
Among these, one, Xltk23, resembled the partial sequences
of human intracellular signalling kinases hMLK1 and 2
(Dorow et al., 1993) and hMLK3 (sprk) (Gallo et al., 1994;
Ing et al., 1994). The Mixed-Lineage Kinases (MLKs) were
so named because their kinase domains resemble both those
of tyrosine and serine/threonine kinases. MLK1, MLK2,
and MLK3 all contain an N-terminal src-homology 3 do-
main (SH3), tandem leucine zipper (LZ) motifs, a basic
region, and a small GTPase binding domain (GBD or CRIB)
that can bind Cdc42 and/or Rac (Burbelo et al., 1995).
Identification and characterisation of xMLK2
Screening of a cDNA library from stage 24 X. laevis
embryos with Xltk23 revealed a cDNA encoding a kinase of
1005 amino acids (aa) with strong homology to hMLK2
(Fig. 1A). This kinase, xMLK2, contained several features
in common with the MLK kinase family (Fig. 1B). xMLK2
contained an amino-terminal SH3 domain followed C-ter-
minally by two closely spaced LZ domains, a stretch of
basic amino acids and a potential GBD. In the case of
hMLK3, the LZ domains have recently been implicated in a
homodimerisation and activation of this kinase (Leung and
Lassam, 1998), while the GBD of hMLK2 was shown to
bind the activated GTPase Rac (Nagata et al., 1998).
Though the sequences of the MLKs are poorly conserved C-
terminally of the GBD, all including xMLK2 contain a high
concentration of proline residues. Forty-six prolines were
found in the last 498 aa of xMLK2. When the predicted
sequence of xMLK2 was compared with hMLKs by using
GCG programs GAP and LINEUP (Devereux et al., 1984)
(Fig. 1A), xMLK2 was found to share 66.6% identity with
hMLK2 but only 49.5% with hMLK3. Homology was con-
centrated in the SH3 domain (67.9% identical to hMLK2),
in the kinase domain (80.8%), the LZ domain (82%), and
the GBD (89.5%).
A message corresponding closely in size to the se-
quenced xMLK2 cDNA of 3975 kb was detected by North-
ern blot at stages 12–14 (late gastrula–early neurula) and
increased in concentration up to stages 40/45 (midorgano-
genesis) (Fig. 2A). Northern analysis also showed that a
second cross-hybridizing RNA species of about 8 kb was
present from stage 10, possibly a splicing precursor, but this
remains to be determined. In the adult frog, xMLK2 mRNA
was found by RT-PCR to be strongly expressed in the brain
and spleen (Fig. 2B), while some expression was also noted
Fig. 5. xMLK2 selectively binds activated Rac, and mediates activation of
JNK. (A) xMLK2 1–659 selectively binds GTP-Rac in pull-down assays.
HA-tagged xMLK2 was expressed in Xenopus embryos and whole embryo
extracts applied to immobilised CDC42, Rac1, and RhoA-GST fusion
proteins precharged with either GTP or GDP. (B) xMLK2 activates JNK
via SEK1/MKK4 in a kinase and extracellular signal-dependent manner.
COS7 cells were transfected with JNK2/SAPK1 and either xMLK2
1–659 (xMLK2), xMLK2 1–659, and mSEKAL or kinase dead xMLK2
1–659 (xMLK2-KR) and were treated with UV (100 J/m2) 1 h before
preparation of whole cell extracts. The data in (B) represent the mean of
four different experiments and are expressed as fold increase with respect
to UV-treated JNK transfected cells.
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in whole ovary, the heart, the liver, and the pancreas. An
antibody was raised against the first 154 amino acids of
recombinant xMLK2p and was used in immunoblotting
experiments with total protein extracts from various tissues.
A cross-reacting protein of 110–115 kDa was observed
which corresponded in size with xMLK2p as predicted from
the cDNA sequence and corresponded in mobility with the
in vitro translation product of the xMLK2 cDNA. xMLK2p
expression was found to be strong in the brain and spleen
and detectable in the pancreas, heart, muscle (not tested for
mRNA content), and possibly the kidney (Fig. 2C).
Earliest xMLK2 expression is restricted to the cement
gland
Whole-mount in situ hybridization revealed that the ear-
liest expression of xMLK2 detectable by whole-mount in
situ occurred at stage 22 in the developing cement gland
(CG) (Fig. 3A). The CG anlage first begins to stand out
from the rest of the epithelial layer of the ectoderm at stage
16, when its cells elongate. The CG is fully differentiated
and secretion from its cells has begun by stage 28 (Nieuw-
koop and Faber, 1967). xMLK2 expression thus began just
after determination of the CG anlage and was observed to
terminate quite abruptly between stages 29 and 32, just
subsequent to the start of secretion (Fig. 3A–C, E, and F).
Expression of xMLK2 in the CG was first detected over the
whole surface of the anlage (Fig. 3A), but by stage 24,
expression was more predominant towards the edges of the
CG (Fig. 3B). By stage 25, expression was concentrated in
two concentric rings around the CG (Fig. 3C). The pattern
of spatial and temporal expression of xMLK2 at stage 25
closely resembled that of xCG, a mucin gene (Sive et al.,
1989) and early CG marker (Fig. 3D), strongly suggesting
that xMLK2 expression was restricted to the CG tissue
itself.
xMLK2 expression in the differentiating pronephros
By stage 30, xMLK2 expression was clearly evident in
the developing pronephros (Fig. 3E). However, weak ex-
pression in this organ was apparent as early as stage 24/25
(data not shown), and expression continued at least as far as
stage 37 (Fig. 3E to H). Low-level xMLK2 expression in the
Fig. 6. Whole-mount TUNEL staining of X. laevis embryos. (A) At stage
22, no TUNEL staining was detected. (B) At stage 24, TUNEL staining
was observed in the anterior and ventral regions of the embryo. (C and
enlargement in D) At stage 25, strongest staining was observed on the
surface of the eye “E” and in two lines around the cement gland “CG.” (E
and enlargement in F) A similar pattern of staining was detected at stage
27, but now a complete ring of TUNEL staining was observed around the
CG. (G and H, and schematic in I) Sequential transverse sections at the
level of the CG from a whole mount TUNEL-stained stage 27 embryo
showing that apoptotic cells are predominantly located in the outer layers
of CG cells.
Fig. 7. Analysis of the inactivation of xMLK2 using Morpholino. (A) Effect of Morpholino on xMLK2 translation in microinjected embryos. Embryos were
injected with mRNA corresponding to wt xMLK2 cDNA (wt xMLK2) or HA-tagged xMLK2 (HA-xMLK2) in the presence or absence of Morpholino (
or ) and whole protein extracts prepared at stage 14. Immunoblots were probed as in Fig. 2 with a polyclonal antibody raised against amino acids 1–154
of xMLK2 (wt xMLK2) or with an anti-HA monoclonal antibody (HA-xMLK2). In each case, a major and one or two minor protein bands were observed
probably due to protein degradation. (B) Comparative phenotype penetrance of Morpholino injection. One cell of two-cell embryos was injected with 0.4,
1.1, and 3.4 pmole of antisense “Match” or “Mismatch” Morpholino. At stage 44/45, the diameters of both pronephros and eyes were measured. Each
measurement was normalised to the corresponding organ diameter from the noninjected side of the same embryo. The data in (B) are representative of three
independent experiments on embryos from three different frogs. (C) Penetrance of the pronephric phenotype. Embryos in (B) showing greater than 20%
reduction in relative pronephric diameter (50% reduction in pronephric volume) were scored as positive for the phenotype. (D) Coinjection of HA-MLK2
mRNA supressed the xMLK2 Morpholino pronephric phenotype. One cell of two-cell embryos was injected with antisense (AS) Morpholino along with
increasing quantities of HA-xMLK2 mRNA. At stage 44/45, the diameters of both pronephros and eye were measured as in (B), and those embryos showing
a greater than 20% reduction in pronephric diameter (50% volume reduction) were scored as positive for the phenotype. (E) The structure of the xMLK2
dominant negative (DN) construction. LZ refers to the leucine zipper (see Fig. 1B). (F) DN-xMLK2 inhibits pronephros formation. DN-xMLK2 mRNA was
injected into one cell of two-cell embryos, and at stage 44/45, the diameters of pronephros and eye on the injected embryo side were determined and
normalised to those on the uninjected side. In all panels, “n” refers to the number of embryos analysed. In none of the above experiments was a greater than
13% reduction in eye diameter detected, and in the majority of experiments, this figure was no more than 6%, e.g., see data for the eye in (B).
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pronephric duct was observed from stage 32, when the duct
opens and its cells adopt a radial organisation (Fig. 3F–H).
The pronephric anlage condenses at stage 20/21 and the
first or anterior proximal pronephric tubule branch is fully
differentiated and shows a central lumen by stage 30 (see
diagrams in Fig. 4A). At this stage, the second tubule branch
has already begun to differentiate, but the third is still
undifferentiated. At stage 32, the second tubule shows a
lumen, and the third is just beginning to open. As can be
seen in Fig. 4A, the expression of xMLK2 in the pronephros
closely followed the differentiation of each of the three
proximal tubule branches, maximum expression displacing
posteriorly as each branch differentiated. Further, expres-
sion appeared to be restricted to the tubule branches and
probably to the connecting and common tubules. Sections
of xMLK2-hybridized embryos confirmed that expression
did not occur in the glomus, which lies medial to and behind
the proximal tubules (Fig. 4B and C). At higher resolution,
expression was seen to be associated with the epithelia
forming the proximal pronephric tubules (Fig. 4D–F). Thus,
xMLK2 expression in the differentiating pronephros corre-
lated temporally and spatially with epithelialization of the
proximal pronephric tubules.
xMLK2 contains a functional GBD
The mammalian MLKs contain potential G-protein-bind-
ing domains (GBD), also referred to as CRIB domains.
Within its potential GBD, xMLK2 was 89% homologous
with hMLK2 and 78% with hMLK3 (Fig. 1). Previous
biochemical studies on hMLK2 and -3 revealed that these
proteins bind directly to the GTPases Cdc42 and Rac via the
GBD, hMLK2 being selective for Rac and hMLK3 for
Cdc42 (Burbelo et al., 1995; Nagata et al., 1998). We
therefore first asked whether xMLK2 bound either of these
GTPases. A total protein extract from microinjected em-
bryos expressing full-length epitope-tagged xMLK2 was
incubated with immobilised bacterially expressed GST fu-
sions of Cdc42, Rac1, or RhoA preloaded with either GDP
or GTP (Fig. 5A). xMLK2 was found to bind detectably
only to GTP-Rac1, and this binding required the GBD since
no binding was seen when this domain was deleted (data not
shown). Thus, xMLK2 showed the same specificity for
Rac1 over Cdc42 and RhoA, as does human MLK2 (Nagata
et al., 1998). This further reinforces the identification of the
Xenopus protein as an MLK2 orthologue.
XMLK2 mediates the response of JNK to UV irradiation
in COS7 cells
Overexpression of hMLK2 and hMLK3 in mammalian
cell lines, including COS7 cells, has been shown to lead to
a constitutive activation of JNK (Hirai et al., 1997; Rana et
al., 1996; Teramoto et al., 1996). hMLK3 was also found to
activate SEK1/MKK4 by direct phosphorylation, and JNK
activation could be blocked by using a dominant negative
form of SEK1. When xMLK2 was expressed in COS7 cells
in the absence of an extracellular stimulus, JNK activity was
unaffected (UV tracks in Fig. 5B). However, when the
xMLK2-expressing cells were subjected to stimulation by
UV irradiation, a 3-fold increase in JNK activation was
observed as compared with control cells. Mutation of the
ATP binding site, producing the dominant negative
xMLK2KR, abolished this enhanced activation (down to 1.1
times control levels). Further, coexpression of the dominant
negative mutant of SEK1 (mSEKAL) significantly attenu-
ated the enhancement of JNK activation by xMLK2 (to
1.8-fold), suggesting that, as previously demonstrated for
hMLK2 and -3, activation of JNK by xMLK2 passed at least
in part via this MAPKK.
xMLK2 expression correlates with the onset of apoptosis
in the cement gland but not in the pronephros
JNK activation has been shown to sometimes correlate
with and possibly induce apoptosis in vivo (e.g., Basu and
Kolesnick, 1998; Dhanasekaran and Reddy, 1998; Kuan et
al., 1999; Low et al., 1999). Furthermore, expression of
hMLK2 in Swiss 3T3 cells has been shown to induce cell
death within 20 h, probably via apoptosis (Nagata et al.,
1998). We have shown that xMLK2 expression within the
pronephros was both spatially and temporally correlated
with the formation and opening of the pronephric tubules, a
process requiring a mesenchyme-to-epithelial transition and
possibly also a degree of cell death, though the latter has not
yet been demonstrated in vivo. On the other hand, CG
differentiation has not previously been shown to involve
apoptosis, though the cells do secrete copious amounts of
mucus and the gland begins to degenerate at stage 47 and
disappears by stage 49.
To determine whether xMLK2 expression correlated
with the onset of programmed cell death (PCD) via apopto-
sis in embryo, we performed whole-mount TUNEL assays
(see Materials and methods) to detect DNA breaks. At stage
22, no TUNEL staining was detected (Fig. 6A), but by stage
24, apoptotic cells were observed over the ventrolateral
head and anterioventral regions (Fig. 6B). By stage 25,
TUNEL staining was predominantly localised over the eye
anlage and at the inner boundary of the differentiating
cement gland. This latter staining colocalised with xMLK2
expression at the same stage (compare Fig. 6C and D with
Fig. 3C). By stage 27, a band of apoptotic cells delineated
the differentiating cement gland and corresponded closely
with the strong xMLK2 expression noted around this stage
(e.g., compare Fig. 6E and F with Fig. 3E). Sectioning of
TUNEL-stained embryos at stage 27 (Fig. 6G–I), revealed
that apoptotic cells of the CG occurred predominantly
within the outer layers of cells, while subsequent sections
(data not shown) revealed that, as expected (Hensey and
Gautier, 1998), apoptosis over the eye anlage occurred ex-
clusively within the epithelium. [Apoptosis in the CG was
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not observed in a recent study in Xenopus (Hensey and
Gautier, 1998.) We have reproduced our observation several
times and presently have no clear explanation for this dis-
crepancy but suggest that it may be related to the degree of
protease treatment of the embryos. The CG secretes copious
amounts of mucus that may interfere with polymerase pen-
etration during the TUNEL assay. In contrast to the clear
observation that apoptosis correlated with xMLK2 expres-
sion within the CG, we were unable to detect apoptosis
within the developing pronephros either before or during the
opening of the pronephric tubules or duct.
xMLK2 is essential for pronephros and cement gland
development
Many studies have shown that Morpholino antisense
oligonucleotides are powerful tools to specifically inactivate
mRNA translation (Heasman, 2002). To study the role of
xMLK2 during X. laevis development, we used an antisense
Morpholino corresponding to nucleotide 4 to 21 of
xMLK2 mRNA sequence in comparison with a Morpholino
in which four mismatches had been introduced (see Mate-
rials and methods). To determine that the “match” anti-
xMLK2 Morpholino specifically and efficiently targeted
xMLK2 production, we injected it into two-cell embryos in
combination with either wt xMLK2 mRNA (Wt xMLK2) or
mRNA encoding the HA-tag xMLK2 (HA-xMLK2). Due to
addition of the epitope tag, translation on the latter clone
initiated 39 nucleotides upstream of the sequence targeted
by the Morpholino and hence should not be affected. As
expected, the Morpholino efficiently blocked production of
wt xMLK2 but did not block production of HA-xMLK2
(Fig. 7A).
Embryos were injected at the two-cell stage with the
antisense Morpholino, and their development followed. At
stage 40, the embryos showed a significant reduction in the
elongation of cement gland (CG) cells on the injected side
(*, in Fig. 8A). This elongation step is the last event in the
differentiation of the CG. Sectioning of the CG revealed that
CG cell nuclei of the affected cells were more closely
associated with the basal membrane than those on the un-
injected side (*, in Fig. 8B). Embryos also often showed a
near complete absence of pronephric tubule formation on
the Morpholino-injected side (*, in Fig. 8C–G). Immuno-
histocytochemistry experiments on Morpholino-injected
embryos using the pronephric placode and tubule marker
C3G (Vize et al., 1995) showed severely reduced staining
and no evidence of branching at stage 36 (compare Fig. 8C
and D). At stage 40, a pronephric tubule artifact could
sometimes be seen on the injected side of the embryos (Fig.
8E and G), while in longitudinal sections, one or two sack-
like structures could sometimes be discerned (Fig. 8F).
From stage 32 to 37, xMLK2 was also expressed in the
brain (Fig. 3F–H). In the Morpholino-injected embryos, the
forebrain was slightly reduced in size (Fig. 8H), though no
obvious effect on the midbrain or hindbrain was detected.
To determine the specificity of the pronephric phenotype
indiced by the Morpholino, we compared the effects of the
“match” Morpholino with a four-base mismatch Morpho-
lino (see Materials and methods). One cell of two-cell em-
bryos was injected with increasing quantities of match and
mismatch Morpholino, and the diameters of the pronephros
and eye, a nonexpressing organ, from the injected side of
each embryo were normalised to those on the noninjected
side (Fig. 7B). The average size of the residual pronephros
in match-Morpholino-injected embryos reduced in a dose-
dependent manner to 39% of its normal diameter (6% of its
volume), while the effect on the eye diameter was less than
10% (73% volume). The mismatch Morpholino gave, at
most, 20% reduction in the average pronephric diameter,
only a little greater than the 10% reduction seen for the eye.
Though this suggested that both the match and mismatch
Morpholino injections did have some nonspecific effects on
embryonic development, these effects were clearly distin-
guishable from the specific effect of the match Morpholino
on pronephros development (Fig. 7B). This was confirmed
by using the Tukey–Kramer test, the phenotypes due to
match as compared with mismatch Morpholino being sta-
tistically significant (P 0.0001) for the pronephros but not
for the eye (P  0.35). Since the maximum effect of the
mismatch Morpholino was a 20% reduction in pronephric
diameter (3.4 pmole in Fig. 7B), we used this figure to
define the cutoff between specific and nonspecific proneph-
ric phenotypes. Defining a positive pronephric phenotype as
a greater than 20% reduction in its diameter, the data of Fig.
7B can be summarised in terms of a phenotypic “pen-
etrance” (Fig. 7C) with 95% of embryos showing the phe-
notype after an injection of 3.4 pmole of match Morpholino.
While the match Morpholino inhibited translation of the
wild type xMLK2 mRNA, it had no effect on translation of
the synthetic mRNA encoding an HA-tagged xMLK2 (Fig.
7A). When increasing amounts of mRNA for HA-tagged
xMLK2 were coinjected with 1.2 pmole of match Morpho-
lino, the penetrance of the pronephric phenotype was clearly
reduced in a dose-dependent manner from 60 to under 30%
(Fig. 7D). Thus, exogenous xMLK2 was to a significant
degree able to rescue the effect of the Morpholino, recov-
ering normal pronephric development in over 50% of af-
fected embryos.
Expression of the leucine zipper region of xMLK2
suppresses pronephros development
hMLK3 has been shown to dimerise via its leucine zip-
per homology region, and this dimerisation has an important
function in kinase activation. We therefore argued that ex-
pression of the zipper domains of xMLK2 should act as a
dominant negative of xMLK2 function in vivo. The cDNA
coding the zipper and adjacent basic region of xMLK2 was
fused to EGFP and this construct expressed by mRNA
injection into one cell of two-cell embryos. At stage
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44/45, the diameters of both pronephros and eye were then
measured as above. While this “dominant negative” (DN)
xMLK2 construction had no significant effect on eye devel-
opment (9%), the pronephric diameter was reduced in a
dose-dependent manner, 65% penetrance being achieved at
an injection of 1.5 ng of mRNA per embryo. This observa-
tion not only confirms the importance of xMLK2 to pro-
nephric development but also suggests that also in vivo the
zipper domains of the MLKs is of crucial importance to
their activity.
Discussion
We have isolated a Xenopus orthologue of MLK2 and
shown that, like its human counterpart, it functions as a
MAPKKK for the JNK signalling pathway. xMLK2 is ex-
pressed in a tissue-restricted manner during early develop-
ment and hence has the potential to mediate cell-specific
transduction of extracellular signals. The first expression of
xMLK2 occurs exclusively in the cement gland (CG) pri-
mordium, and its expression persists throughout CG differ-
entiation. Subsequently, xMLK2 is expressed in the brain
and in the pronephros. xMLK2 was found to be expressed in
pronephric tubules and not in the pronephric duct, further
supporting evidence that the tubules have an independent
developmental origin to that of the duct and may come
under independent genetic control (Bra¨ndli, 1999; Vize et
al., 1995). The formation of both pronephric duct and tu-
bules otherwise appears structurally very similar; however,
their functions are quite different. The differential expres-
sion of xMLK2 may, therefore, provide a key to understand-
ing how nonoverlapping developmental controls can lead to
such physically similar but functionally distinct patterns of
differentiation.
In both the CG and the pronephric tubules, an epithelium
is formed concomitant with the expression of xMLK2. Dur-
ing the period of xMLK2 expression, the cells of the CG
align and elongate. xMLK2 expression begins after deter-
mination of the CG anlage and terminates quite abruptly
between stages 29 and 32, just subsequent to the start of
secretion at stage 28. Antisense inactivation of xMLK2
expression led to reduced elongation of the cement gland
cells. The expression of xMLK2 in the pronephros closely
followed the differentiation of each proximal pronephric
tubule, maximal expression displacing posteriorly as each
tubule differentiated. Hence, xMLK2 expression corre-
sponded with the epithelialization of the pronephric tubules.
Antisense inactivation of xMLK2 was shown to severely
impair normal tubule development and expression of the
proximal tubule marker 3G8 (Vize et al., 1995). This effect
was specific and could be rescued by the coexpression of an
epitope tagged xMLK2. Further, expression of only the
leucine zipper and basic region of xMLK2 had a dominant
negative effect on pronephric development, confirming the
antisense data and suggesting that one or both of these
regions are crucial to in vivo function.
Like its human orthologue, xMLK2 binds preferentially
to the small GTPase Rac, which has been implicated in
lamellipodia (ruffle) formation (Mackay and Hall, 1998).
Another member of the MLK family, MLK3, has been
shown to be equally selective for CDC42, which is impli-
cated in the formation of filopodia. Thus, xMLK2 has the
potential to respond selectively to Rac activation. xMLK2
Fig. 8. Phenotypic effects of xMLK2 Antisense Morpholino on X. laevis
development. (A) Frontal view of a stage 40 X. laevis Morpholino-injected
embryo showing a defect in the elongation of the cement gland cells
(arrowed). The line indicates the left–right symmetry. (B) Transverse
section of the embryo shown in (A) at the level of the cement gland, stained
with hematoxylin–eosin staining. (C and D) Immunohistocytochemistry
using the pronephros marker 3G8 (Vize et al., 1995) on a stage 36 embryo
injected with xMLK2 Morpholino. (C) Corresponds to the control side and
(D) to the injected side of embryo. (E) Dorsal view of a stage 45 embryo
showing a reduction of pronephros development on the injected side. (F)
Longitudinal section of a stage 45 embryo showing the almost complete
absence of pronephric tubules on the Morpholino-injected side. (G) Dis-
sected pronephros from uninjected and injected sides of a stage 45 embryo.
(H) The reduced forebrain in a stage 45 injected embryo. The right
forebrain hemisphere is smaller than the left hemisphere. Antisense
xMLK2 Morpholino injection was to the right in each panel, except for (C)
and (D). The bar in the bottom righthand corner of each panel corresponds
to 0.5 mm.
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activates JNK in an extracellular signal-dependent manner
via the SAPK-kinase MKK4/SEK1 in Cos7 cells. In pre-
liminary work, we have also found that xPAK1 (Faure et al.,
1997; Islam et al., 2000), a potential MAPKKKK of the
JNK pathway, is coexpressed with xMLK2 but acts as a
negative regulator of xMLK2, suggesting that its function in
the developing pronephros may be to limit xMLK2 activity
(L.P., unpublished data).
Expression of xMLK2 in the CG occurred concomitantly
with the onset and progression of extensive apoptotic pro-
grammed cell death (PCD) in this organ. This, to our knowl-
edge, is the first suggestion that PCD forms part of CG
differentiation. Our data suggest that, in fact, CG cells may
begin to degenerate while still producing mucus, possibly a
means of rapidly releasing large amounts of mucus as the
CG becomes functional. However, we were unable to detect
apoptosis associated with xMLK2 expression in the pro-
nephric tubules. Thus, either we overlooked a minor number
of apoptotic events or apoptosis simply did not occur during
tubule formation. In either scenario, our data show that
apoptosis cannot simply be correlated with xMLK2 expres-
sion and must presumably depend on local PCD signalling
events, some of which may or may not be transduced by
xMLK2. Data on the role of JNK in the induction of apo-
ptosis are extensive but are equivocal. In many cases, JNK
activity has been correlated with and indeed shown to in-
duce apoptosis, and JNK is required at least for some apo-
ptotic events in vivo (Basu and Kolesnick, 1998; Dhanas-
ekaran and Reddy, 1998; Kuan et al., 1999). However, the
activation of JNK has been shown to be not essential for
apoptosis per se (e.g., Low et al., 1999). Further, data from
Drosophila argue against a predominant role for DJNK
(basket) in PCD (Noselli and Agne`s, 1999).
The pronephric pattern of xMLK2 expression closely
follows that of Wnt4a and of EphA4, both molecules being
present in the pronephric placode and restricted to the de-
veloping tubules (Bra¨ndli, 1999). Both Wnt4a and EphA4
have the potential to activate the JNK pathway, while the
Wnt planar cell polarity (PCP) pathway is implicated in the
formation and migration of epithelial cell sheets (e.g.,
Becker et al., 2000; McEwen et al., 2000; Noselli and
Agne`s, 1999; Schmucker and Zipursky, 2001; Wahl et al.,
2000). Further, the PCP pathway in Drosophila was re-
cently shown to pass through a homologue of the MLK
(Stronach and Perrimon, 2002). Thus, it will now be impor-
tant to determine whether xMLK2 transduces the Wnt
and/or Eph signalling events required for pronephric differ-
entiation.
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